14
Feb
2018
Building a Cancer R&D Engine To Last: David Schenkein on The Long Run
Today’s guest on The Long Run podcast is David Schenkein. He’s the CEO of Cambridge, Mass.-based Agios Pharmaceuticals. Agios was founded a decade ago on the then-provocative idea of fighting cancer via new understanding of metabolic pathways that get hijacked by cancer cells. The company has grown up quite a bit since. It went from concept to new chemical entities... Read More